caa a22 4500 477072437 CHVBK 20180405111430.0 cr unu---uuuuu 170330e19960901xx s 000 0 eng 10.1007/BF00051115 doi (NATIONALLICENCE)springer-10.1007/BF00051115 Five-year mortality after acute myocardial infarction in relation to previous history, level of initial care, complications in hospital, and medication at discharge [Elektronische Daten] [Johan Herlitz, Angela Bång, Margareta Sjölin, Björn Karlson] Summary: The purpose of this study was to describe the prognosis during 5 years of follow-up in a consecutive population of patients discharged from hospital after acute myocardial infarction (AMI) in relation to clinical history, level of initial care, complications during hospitalization, and medication at discharge. All patients admitted to a single hospital from February 15, 1986 to November 9, 1987 due to AMI, regardless of age and whether or not they were treated in the coronary care unit, and who were discharged alive from hospital were included in the study. There were 862 patients with AMI, 740 of whom were discharged alive. Information on medication at discharge was available in 713 patients (96%). In a multivariate analysis taking into account age, sex, history of cardiovascular diseases, whether patients were admitted to coronary care unit or not, complications during hospitalization, and medication at discharge, the following factors appeared to be independent predictors of mortality: age (p<0.001), history of AMI (p<0.001), congestive heart failure in hospital (p<0.001), whether beta-blockers had been prescribed at discharge (p<0.01), and a history of diabetes (p<0.01). This study indicates that in consecutive patients surviving the hospital phase of AMI, the development of complications while in hospital and the manner in which medication was prescribed at discharge independently influenced their longterm prognosis, but age was the most important factor in long-term prognosis. Kluwer Academic Publishers, 1996 acute myocardial infarction nationallicence complications nationallicence medication nationallicence prognosis nationallicence Herlitz Johan Division of Cardiology, Sahlgrenska University Hospital, Göteborg, Sweden aut Bång Angela Division of Cardiology, Sahlgrenska University Hospital, Göteborg, Sweden aut Sjölin Margareta Division of Cardiology, Sahlgrenska University Hospital, Göteborg, Sweden aut Karlson Björn Division of Cardiology, Sahlgrenska University Hospital, Göteborg, Sweden aut Cardiovascular Drugs and Therapy Kluwer Academic Publishers 10/4(1996-09-01), 485-490 0920-3206 10:4<485 1996 10 10557 https://doi.org/10.1007/BF00051115 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF00051115 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Herlitz Johan Division of Cardiology, Sahlgrenska University Hospital, Göteborg, Sweden aut NATIONALLICENCE 700 1- Bång Angela Division of Cardiology, Sahlgrenska University Hospital, Göteborg, Sweden aut NATIONALLICENCE 700 1- Sjölin Margareta Division of Cardiology, Sahlgrenska University Hospital, Göteborg, Sweden aut NATIONALLICENCE 700 1- Karlson Björn Division of Cardiology, Sahlgrenska University Hospital, Göteborg, Sweden aut NATIONALLICENCE 773 0- Cardiovascular Drugs and Therapy Kluwer Academic Publishers 10/4(1996-09-01), 485-490 0920-3206 10:4<485 1996 10 10557 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer